newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences to Participate at the 2022 H.C. Wainwright BioConnect Conference

WATERTOWN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune respo